Amyloidosis Fellowship Program

ISA awards a limited number of amyloidosis fellowships each year, with a focus on clinical training in all types of amyloidosis. The number of fellowships will depend on funds available.

In 2021-2024, ISA collaborated with Pfizer to offer cardiac amyloidosis fellowships. Starting with 2024-2025 fellowships, ISA has expanded its fellowship program to include all kinds of amyloidosis and multiple sponsors. With this new, expanded program, potential fellows and their host institutions negotiate the details of fellowships, then jointly apply to ISA for a fellowship grant.

The goals of ISA’s fellowship program are to:

    • train physicians to diagnose and manage all types of amyloidosis, especially ATTR and AL amyloidosis
    • develop the next generation of leading clinicians in the amyloidosis field
    • encourage collaboration among institutions to enhance to address unanswered research questions in the field.
    • provide a training experience and mentoring on the conduct of rigorously designed clinical research through participation in amyloidosis-related investigations.

Fellows are expected to be part of ISA educational efforts and impart their acquired knowledge and experience in diagnosing and managing amyloidosis, all of which should translate into decreased delays in diagnosis, more accurate diagnoses, and improved management of amyloidosis in their home regions or under-served areas.

List of ISA fellows and mentors

The application period for the 2025-2026 Fellowship Program has ended.